在线询价
| 姓 名： | |
| 性别： | |
| 公 司： | * |
| 地 址： | * |
| 行 业： | * |
| 职 务： | * |
| 电 话： | * |
| 手 机： | |
| 传 真： | |
| E-mail： | |
| 留言内容： | * |
Lux® Amylose-2手性柱
品牌：
Lux® Cellulose-1手性柱
品牌：
Lux® Cellulose-2手性柱
品牌：
Lux® Cellulose-3手性柱
品牌：
Lux® Cellulose-4手性柱
品牌：Chirex长寿命手性色谱柱
型 号：Chirex 长寿命手性色谱柱
手性分离对制药和生物技术行业以及其它天然产物化学的发展越来越重要。光学活性治疗药物需要有选择性和灵敏的技术。
政府法规也继续促使和要求开发出快速、准确和重现的方法分析和纯化手性化合物
高手性选择性
快速运行时间
耐用，柱寿命长
容易放大至制备
可以直接/间接分离手性胺、氨基酸、羟基酸、醇、羧酸、酮、醚和酯
|
供货信息：货号 |
品牌 |
固定相 |
粒径(µm) |
孔径(Å) |
长度(mm) |
内径(mm) |
|
00B-3001-E0 |
Chirex |
3001 (R)-phenylglycine and 3,5-dinitrobenzoic acid |
5 |
120 |
50 |
4.60 |
|
00B-3005-E0 |
Chirex |
3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid |
5 |
120 |
50 |
4.60 |
|
00B-3010-E0 |
Chirex |
3010 (S)-valine and 3,5-dinitroaniline |
5 |
120 |
50 |
4.60 |
|
00B-3011-E0 |
Chirex |
3011 (S)-tert-leucine and 3,5-dinitroaniline |
5 |
120 |
50 |
4.60 |
|
00B-3012-E0 |
Chirex |
3012 (R)-phenylglycine and 3,5-dinitroaniline |
5 |
120 |
50 |
4.60 |
|
00B-3014-E0 |
Chirex |
3014 (S)-valine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
50 |
4.60 |
|
00B-3018-E0 |
Chirex |
3018 (S)-proline and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
50 |
4.60 |
|
00B-3020-E0 |
Chirex |
3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
50 |
4.60 |
|
00B-3022-E0 |
Chirex |
3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine |
5 |
120 |
50 |
4.60 |
|
00B-3126-E0 |
Chirex |
3126 (D)-penicillamine |
5 |
110 |
50 |
4.60 |
|
00F-3001-E0 |
Chirex |
3001 (R)-phenylglycine and 3,5-dinitrobenzoic acid |
5 |
120 |
150 |
4.60 |
|
00F-3005-E0 |
Chirex |
3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid |
5 |
120 |
150 |
4.60 |
|
00F-3010-E0 |
Chirex |
3010 (S)-valine and 3,5-dinitroaniline |
5 |
120 |
150 |
4.60 |
|
00F-3011-E0 |
Chirex |
3011 (S)-tert-leucine and 3,5-dinitroaniline |
5 |
120 |
150 |
4.60 |
|
00F-3012-E0 |
Chirex |
3012 (R)-phenylglycine and 3,5-dinitroaniline |
5 |
120 |
150 |
4.60 |
|
00F-3020-B0 |
Chirex |
3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
150 |
2.00 |
|
00F-3020-E0 |
Chirex |
3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
150 |
4.60 |
|
00F-3022-E0 |
Chirex |
3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine |
5 |
120 |
150 |
4.60 |
|
00F-3126-B0 |
Chirex |
3126 (D)-penicillamine |
5 |
110 |
150 |
2.00 |
|
00F-3126-E0 |
Chirex |
3126 (D)-penicillamine |
5 |
110 |
150 |
4.60 |
|
00F-3126-N0 |
Chirex |
3126 (D)-penicillamine |
5 |
110 |
150 |
10.00 |
|
00G-3001-B0 |
Chirex |
3001 (R)-phenylglycine and 3,5-dinitrobenzoic acid |
5 |
120 |
250 |
2.00 |
|
00G-3001-E0 |
Chirex |
3001 (R)-phenylglycine and 3,5-dinitrobenzoic acid |
5 |
120 |
250 |
4.60 |
|
00G-3005-B0 |
Chirex |
3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid |
5 |
120 |
250 |
2.00 |
|
00G-3005-E0 |
Chirex |
3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid |
5 |
120 |
250 |
4.60 |
|
00G-3010-E0 |
Chirex |
3010 (S)-valine and 3,5-dinitroaniline |
5 |
120 |
250 |
4.60 |
|
00G-3010-N0 |
Chirex |
3010 (S)-valine and 3,5-dinitroaniline |
5 |
120 |
250 |
10.00 |
|
00G-3010-P0 |
Chirex |
3010 (S)-valine and 3,5-dinitroaniline |
5 |
120 |
250 |
21.20 |
|
00G-3011-E0 |
Chirex |
3011 (S)-tert-leucine and 3,5-dinitroaniline |
5 |
120 |
250 |
4.60 |
|
00G-3012-E0 |
Chirex |
3012 (R)-phenylglycine and 3,5-dinitroaniline |
5 |
120 |
250 |
4.60 |
|
00G-3012-N0 |
Chirex |
3012 (R)-phenylglycine and 3,5-dinitroaniline |
5 |
120 |
250 |
10.00 |
|
00G-3014-E0 |
Chirex |
3014 (S)-valine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
250 |
4.60 |
|
00G-3014-N0 |
Chirex |
3014 (S)-valine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
250 |
10.00 |
|
00G-3014-P0 |
Chirex |
3014 (S)-valine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
250 |
21.20 |
|
00G-3018-E0 |
Chirex |
3018 (S)-proline and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
250 |
4.60 |
|
00G-3019-E0 |
Chirex |
3019 (S)-tert-leucine and (S)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
250 |
4.60 |
|
00G-3019-P0 |
Chirex |
3019 (S)-tert-leucine and (S)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
250 |
21.20 |
|
00G-3020-D0 |
Chirex |
3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
250 |
4.00 |
|
00G-3020-E0 |
Chirex |
3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
250 |
4.60 |
|
00G-3020-P0 |
Chirex |
3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
250 |
21.20 |
|
00G-3022-D0 |
Chirex |
3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine |
5 |
120 |
250 |
4.00 |
|
00G-3022-E0 |
Chirex |
3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine |
5 |
120 |
250 |
4.60 |
|
00G-3126-B0 |
Chirex |
3126 (D)-penicillamine |
5 |
110 |
250 |
2.00 |
|
00G-3126-E0 |
Chirex |
3126 (D)-penicillamine |
5 |
110 |
250 |
4.60 |
|
03A-3001-E0 |
Chirex |
3001 (R)-phenylglycine and 3,5-dinitrobenzoic acid |
5 |
120 |
30 |
4.60 |
|
03A-3005-B0 |
Chirex |
3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid |
5 |
120 |
30 |
2.00 |
|
03A-3005-E0 |
Chirex |
3005 (R)-1-naphthylglycine and 3,5-dinitrobenzoic acid |
5 |
120 |
30 |
4.60 |
|
03A-3010-E0 |
Chirex |
3010 (S)-valine and 3,5-dinitroaniline |
5 |
120 |
30 |
4.60 |
|
03A-3011-E0 |
Chirex |
3011 (S)-tert-leucine and 3,5-dinitroaniline |
5 |
120 |
30 |
4.60 |
|
03A-3012-E0 |
Chirex |
3012 (R)-phenylglycine and 3,5-dinitroaniline |
5 |
120 |
30 |
4.60 |
|
03A-3014-E0 |
Chirex |
3014 (S)-valine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
30 |
4.60 |
|
03A-3018-E0 |
Chirex |
3018 (S)-proline and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
30 |
4.60 |
|
03A-3019-E0 |
Chirex |
3019 (S)-tert-leucine and (S)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
30 |
4.60 |
|
03A-3020-E0 |
Chirex |
3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine |
5 |
120 |
30 |
4.60 |
|
03A-3022-D0 |
Chirex |
3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine |
5 |
120 |
30 |
4.00 |
|
03A-3022-E0 |
Chirex |
3022 (S)-indoline-2-carboxylic acid and (R)-1-(alpha-napthyl)ethylamine |
5 |
120 |
30 |
4.60 |
|
03A-3126-E0 |
Chirex |
3126 (D)-penicillamine |
5 |
110 |
30 |
4.60 |
